Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $9.50 to $6.00. They now have a "buy" rating on the stock.
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citizens Jmp from $11.00 to $10.00. They now have a "market outperform" rating on the stock.
Evolent Health (NYSE:EVH) had its "outperform" rating reaffirmed by analysts at Citigroup Inc..
Evolent Reports Inducement Award Under NYSE Listing Rule 303A.08
Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.